Fingerprint
Dive into the research topics of 'Leveraging an NQO1 Bioactivatable Drug for Tumor-Selective Use of Poly(ADP-ribose) Polymerase Inhibitors'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Leveraging an NQO1 Bioactivatable Drug for Tumor-Selective Use of Poly(ADP-ribose) Polymerase Inhibitors
Xiumei Huang, Edward A. Motea, Zachary R. Moore, Jun Yao, Ying Dong, Gaurab Chakrabarti, Jessica A. Kilgore, Molly A. Silvers, Praveen L. Patidar, Agnieszka Cholka, Farjana Fattah, Yoonjeong Cha, Glenda G. Anderson, Rebecca Kusko, Michael Peyton, Jingsheng Yan, Xian Jin Xie, Venetia Sarode, Noelle S. Williams, John D. Minna
- Simmons Comprehensive Cancer Center
- Clinical Sciences - Clinical Research Design
- Clinical Sciences
- Pathology
- Pathology
- Biochemistry
- Biochemistry
- The Nancy B. and Jake L. Hamon Center for Therapeutic Oncology Research
- Internal Medicine
- Pharmacology
- Hamon Center For Therapeutic Oncology
- Hematology & Oncology
- Radiation Oncology
- Rad Onc - Other
- Simmons Comprehensive Cancer Center - Research Labs
Research output: Contribution to journal › Article › peer-review
93
Scopus
citations